Konstantinos Xynos, the Chief Medical Officer of $REPL ($REPL), sold 7,246 shares of the company on 11-18-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 6.2% of their shares. Following this trade, they now own 109,885 shares of $REPL stock.
$REPL Insider Trading Activity
$REPL insiders have traded $REPL stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $REPL stock by insiders over the last 6 months:
- KONSTANTINOS XYNOS (Chief Medical Officer) has traded it 2 times. They made 0 purchases and 2 sales, selling 23,127 shares.
- CHRISTOPHER SARCHI (Chief Commercial Officer) sold 5,207 shares.
- EMILY LUISA HILL (Chief Financial Officer) sold 8,938 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$REPL Hedge Fund Activity
We have seen 77 institutional investors add shares of $REPL stock to their portfolio, and 87 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC removed 2,098,300 shares (-100.0%) from their portfolio in Q3 2024
- BRAIDWELL LP added 2,057,460 shares (+203.0%) to their portfolio in Q3 2024
- MILLENNIUM MANAGEMENT LLC removed 1,963,214 shares (-63.0%) from their portfolio in Q3 2024
- CAMBER CAPITAL MANAGEMENT LP removed 1,350,000 shares (-100.0%) from their portfolio in Q3 2024
- STATE STREET CORP added 1,182,181 shares (+102.1%) to their portfolio in Q3 2024
- BAKER BROS. ADVISORS LP added 1,000,000 shares (+10.0%) to their portfolio in Q3 2024
- JEFFERIES FINANCIAL GROUP INC. removed 1,000,000 shares (-100.0%) from their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
